Raúl Navaridas

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 23, 2026
miR-424(322)<sup>~</sup>503 impairs colon cancer progression driven by PTEN deficiency.

Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas

|Oct 06, 2025
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)<sup>~</sup>503.

Maria Vidal-Sabanés, Núria Bonifaci, Raúl Navaridas

|Sep 26, 2023
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

Raúl Navaridas, Maria Vidal-Sabanés, Anna Ruiz-Mitjana

|Aug 02, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.

Philippe A Cassier, Raul Navaridas, Melanie Bellina

|Jul 28, 2022
Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma.

Tània Cemeli, Marta Guasch-Vallés, Marina Ribes-Santolaria

|Jun 20, 2022
M-CSF as a therapeutic target in BRAF<sup>V600E</sup> melanoma resistant to BRAF inhibitors.

C Barceló, P Sisó, I de la Rosa

Pageof 1